598
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

A clinical study of the combined use of bromocriptine and speech and language therapy in the treatment of a person with aphasia

, , &

REFERENCES

  • Albert, M. L., Bachman, D. L., Morgan, A., & Helm-Estabrooks, N. (1988). Pharmacotherapy for aphasia. Neurology, 38, 877–879.
  • Alexander, M. P. (2006). Impairments for procedures for implementing complex language are due to disruption of frontal attention processes. Journal of the International Neuropsychological Society, 12, 236–247.
  • Amunts, K., Lenzen, M., Friederici, A. D., Schleicher, A., Morosan, P., Palomero-Gallagher, N., & Zilles, K. (2010). Broca’s region: Novel organizational principles and multiple receptor mapping. PLoS Biology, 8, e1000489.
  • Ashtary, F., Janghorbani, M., Chitsaz, A., Reisi, M., & Bahrami, A. (2006). A randomized, double-blind trial of bromocriptine efficacy in nonfluent aphasia after stroke. Neurology, 66, 914–916.
  • Berthier, M. L. (1999). Transcortical Aphasias. Hove: Psychology Press.
  • Berthier, M. L. (2005). Poststroke aphasia. Epidemiology, pathophysiology and treatment. Drugs & Aging, 22, 163–182.
  • Berthier, M. L. (2012). Pharmacological interventions boost language and communication treatment effects in chronic post-stroke aphasia (p. 23). Presented in the symposium Fortschritte in Neurowissenschaft und Neurorehabilitation der Sprache. 85. Kongress der Deutschen Gesellschaft für Neurologie mit Fortbildungsakademie. Hamburg. Hauptprogramm.
  • Berthier, M. L., & Pulvermüller, F. (2011). Neuroscience insights improve neurorehabilitation of poststroke aphasia. Nature Review Neurology, 7, 86–97.
  • Berthier, M. L., Pulvermüller, F., Dávila, G., García-Casares, N., & Gutiérrez, A. (2011). Drug therapy of post-stroke aphasia: A review of current evidence. Neuropsychology Review, 21, 302–317.
  • Bowen, A., Hesketh, A., Patchick, E., Young, A., Davies, L., Vail, A., … Tyrell, P. (2012). Effectiveness of enhanced communication therapy in the first four months after stroke for aphasia and dysarthria: A randomised controlled trial. British Medical Journal, 345, e4407.
  • Bragoni, M., Altieri, M., Di Piero, V., Padovani, A., Mostardini, C., & Lenzi, G. L. (2000). Bromocriptine and speech therapy in non-fluent chronic aphasia after stroke. Neurological Sciences, 21, 19–22.
  • Bromocriptine in MIMS. Retrieved from http://www.mims.co.uk/.
  • Costello, A. L., & Warrington, E. W. (1986). Dynamic aphasia: The selective impairment of verbal planning. Cortex, 25, 103–114.
  • Crosson, B., Bacon Moore, A., Gopinath, K., White, K. D., Wierenga, C. E., Gaiefsky, M. E., … Gonzalez Rothi, L. J. (2005). Role of the right and left hemispheres in recovery of function during treatment of intention in aphasia. Journal of Cognitive Neuroscience, 17, 392–406.
  • Crosson, B., Fabrizio, K. S., Singletary, F., Cato, M. A., Wierenga, C. E., Parkinson, R. B., … Gonzalez Rothi, L. J. (2007). Treatment of naming in nonfluent aphasia through manipulation of intention and attention: A phase 1 comparison of two novel treatments. Journal of the International Neuropsychological Society, 13, 582–594.
  • Enderby, P., Wood, V., & Wade, D. (1987). Frenchay Aphasia Screening Test (FAST). Windsor: NFER-NELSON.
  • Engelter, S. T., Urscheler, N., Baronti, F., Vuadens, P., Koch, J., Frank, M., … Jenni, W. (2012). Frequency and determinants of using pharmacological enhancement in the clinical practice of in-hospital stroke rehabilitation. European Neurology, 68, 28–33.
  • Gold, M., Nadeau, S. E., Jacobs, D. H., Adair, J. C., Gonzalez Rothi, L., & Heilman, K. M. (1997). Adynamic aphasia: A transcortical motor aphasia with defective semantic strategy formation. Brain and Language, 57, 374–393.
  • Goodglass, H., Kaplan, E., & Barresi, B. (2001). BDAE-3: The Boston diagnostic aphasia examination (3rd ed.). Philadelphia, PA: Lippincott, Williams & Wilkins.
  • Gorgoraptis, N., Mah, Y. H., Machner, B., Singh-Curry, V., Malhotra, P., Hadji-Michael, M., … Husain, M. (2012). The effects of the dopamine agonist rotigotine on hemispatial neglect following stroke. Brain, 135, 2478–2491.
  • Gratton, C., Nomura, E. M., Pérez, F., & D’Esposito, M. (2012). Focal brain lesions to critical locations cause widespread disruption of the modular organization of the brain. Journal of Cognitive Neuroscience, 24, 1275–1285.
  • Gupta, S. R., Mlcoch, A. G., Scolaro, C., & Moritz, T. (1995). Bromocriptine treatment of nonfluent aphasia. Neurology, 45, 2170–2173.
  • Johansen-Berg, H., Gutman, D. A., Behrens, T. E. J., Matthews, P. M., Rushworth, M. F. S., Katz, E., … Mayberg, H. S. (2008). Anatomical connectivity of the subgenual cingulate region targeted with deep brain stimulation for treatment-resistant depression. Cerebral Cortex, 18, 1374–1383.
  • Jorge, R. E., Acion, L., Moser, D., Adams Jr, H. P., & Robinson, R. G. (2010). Escitalopram and enhancement of cognitive recovery following stroke. Archives of general psychiatry, 67, 187–196.
  • Jorge, R. E., Starkstein, S. E., & Robinson, R. G. (2010). Apathy following stroke. Canadian Journal of Psychiatry, 55, 350–354.
  • Kauhanen, M. L., Korpelainen, J. T., Hiltunen, P., Maatta, R., Mononen, H., Brusin, E., … Myllylä, V. V. (2000). Aphasia, depression, and non-verbal cognitive impairment in ischaemic stroke. Cerebrovascular Diseases, 10, 455–461.
  • Kay, J., Lesser, R., & Coltheart, M. (1992). Psycholinguistic Assessments of Language Processing in Aphasia (PALPA). Hove: Erlbaum.
  • Kertesz, A. (1997). Recovery of aphasia. In T. E. Feinberg & M. J. Farah (Eds.), Behavioral neurology and neuropsychology. New York, NY: McGraw-Hill.
  • Kertesz, A. (2007). Western aphasia battery: Revised. San Antonio, TX: Psychological Corporation.
  • Knecht, S., Breitenstein, C., Bushuven, S., Wailke, S., Kamping, S., Flöel, A., … Bernd Ringelstein, E. (2004). Levodopa: Faster and better word learning in normal humans. Annals of Neurology, 56, 20–26.
  • Leemann, B., Laganaro, M., Chetelat-Mabillard, D., & Schnider, A. (2011). Crossover trial of subacute computerized aphasia therapy for anomia with the addition of either levodopa or placebo. Neurorehabilitation and Neural Repair, 25, 43–47.
  • Lester, D. B., Rogers, T. D., & Blaha, C. D. (2010). Acetylcholine-dopamine interactions in the pathophysiology and treatment of CNS disorders. CNS Neuroscience & Therapeutics, 16, 137–162.
  • Levy, R., & Dubois, B. (2006). Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. Cerebral Cortex, 16, 916–928.
  • Luria, A. R., & Tsvetkova, L. S. (1968). The mechanism of “dynamic aphasia.” Foundations of Language, 4, 296–307.
  • Mahoney, F. I., & Barthel, D. (1965). Functional evaluation: The Barthel Index. Maryland State Medical Journal, 14, 56–61.
  • Marin, R. S., Fogel, B. S., Hawkins, J., Duffy, J., & Krupp, B. (1995). Apathy: A treatable syndrome. Journal of Neuropsychiatry and Clinical Neuroscience, 7, 23–30.
  • Mark, G. P., Shabani, S., Dobbs, L. K., & Hansen, S. T. (2011). Cholinergic modulation of mesolimbic dopamine function and reward. Physiology and Behavior, 104, 76–81.
  • Mayberg, H. S., Lozano, A. M., Voon, V., McNeely, H. E., Seminowicz, D., Hamani, C., … Kennedy, S. H. (2005). Deep brain stimulation for treatment-resistant depression. Neuron, 45, 651–660.
  • Menke, R., Meinzer, M., Kugel, H., Deppe, M., Baumgartner, A., Schiffbauer, H., … Breitenstein, C. (2009). Imaging short- and long-term training success in chronic aphasia. BMC Neuroscience, 10, 118.
  • Paolucci, S. (2008). Epidemiology and treatment of post-stroke depression. Neuropsychiatric Disease and Treatment, 4, 145–154.
  • Powell, J. H., AlAdawi, S., Morgan, J., & Greenwood, R. J. (1996). Motivational deficits after brain injury: Effects of bromocriptine in 11 patients. Journal of Neurology Neurosurgery and Psychiatry, 60, 416–421.
  • Ramsberger, G., & Marie, B. (2007). Self-administered cued naming therapy: A single-participant investigation of a computer-based therapy program replicated in four cases. American Journal of Speech-Language Pathology, 16, 343–358.
  • Raven, J. C. (1976). Coloured progressive matrices. San Antonio, TX: Harcourt Assessment.
  • Raymer, A. M. (2003). Treatment of adynamia in aphasia. Frontiers in bioscience, 8, S845–S851.
  • Raymer, A. M., Bandy, D., Adair, J. C., Schwartz, R. L., Williamson, D. J. G., Gonzalez Rothi, L. J., … Heilman, K. M. (2001). Effects of bromocriptine in a patient with crossed nonfluent aphasia: A case report. Archives of Physical Medicine and Rehabilitation, 82, 139–144.
  • Reitan, R. M. (1958). Validity of the Trail Making test as an indicator of organic brain damage. Perceptual Motor Skills, 8, 271–276. Also available in: Lezak, M. D., Howieson, D. B., Bigler, E. D. & Tranel, D. (2012). Neuropsychological assessment (5th ed.). New York, NY: Oxford University Press.
  • Robertson, I., Ward, T., Ridgeway, V., & Nimmo-Smith, I. (1994). The test of everyday attention. London: Harcourt Assessment.
  • Robinson, G., Blair, J., & Cipolotti, L. (1998). Dynamic aphasia: An inability to select between competing verbal responses? Brain, 121, 77–89.
  • Sabe, L., Salvarezza, F., García Cuerva, A., Leiguarda, R., & Starkstein, S. (1995). A randomized, double-blind, placebo-controlled study of bromocriptine in nonfluent aphasia. Neurology, 45, 2272–2274.
  • Seniów, J., Litwin, M., Litwin, T., Leśniak, M., & Członkowska, A. (2009). New approach to the rehabilitation of post-stroke focal cognitive syndrome: Effect of levodopa combined with speech and language therapy on functional recovery from aphasia. Journal of the Neurological Sciences, 15, 214–218.
  • Starkstein, S. E., & Manes, F. (2000). Apathy and depression following stroke. CNS Spectrums, 5, 43–50.
  • Willems, R. M., & Varley, R. (2010). Neural insights into the relation between language and communication. Frontiers in Human Neuroscience, 4. doi:10.3389/fnhum.2010.00203
  • Whyte, E. M., Lenze, E. J., Butters, M., Skidmore, E., Koenig, K., Dew, M. A., … Munin, M. C. (2008). An open-label pilot study of acetylcholinesterase inhibitors to promote functional recovery in elderly cognitively impaired stroke patients. Cerebrovascular Diseases, 26, 317–321.
  • World Health Organisation. (2001). International Classification of Functioning, Disability and Health [world wide web] Retrieved February 2013, from http://www.who.int/classifications/icf/en/

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.